A Trial of Lopinavir–Ritonavir in Covid-19

After a review of the findings of Cao et al. (published in the Journal online on March 18), 1 many clinicians are abandoning the use of lopinavir–ritonavir for the treatment of Covid-19. We consider this action to be premature. […]

Click here to view original web page at A Trial of Lopinavir–Ritonavir in Covid-19